$921.49
6.450.70%
At Close: -
$920.75
-0.74-0.08%
After Hours: Sep 20, 7:25 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for Eli Lilly (NYSE:LLY) Stock
Eli Lilly Stock (NYSE: LLY)
Categories: All
Friday, September 20, 2024
- US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
- FTC Sues Units Of CVS Health , Cigna , And Un...
- In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry
- Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
Wednesday, September 18, 2024
Tuesday, September 17, 2024
Monday, September 16, 2024
Friday, September 13, 2024
Thursday, September 12, 2024
Wednesday, September 11, 2024
- Roche Says In CT-996 Phase 1 Trial, 4-Week We...
- Could Elon Musk Become The World's First Trillionaire? Tesla's Success Could Make It Happen As Early As...
- Ozempic Maker Novo Nordisk Touts Encouraging Data From New Obesity Pill Showing Double Weight Loss Compared To Wegovy
- Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval
Tuesday, September 10, 2024
- Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 20 Years
- Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
- Eli Lilly's Once-Weekly Insulin Efsitora Alfa...
- Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
Monday, September 09, 2024
Friday, September 06, 2024
Thursday, September 05, 2024
- Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
- Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation
- Eli Lilly shares are trading lower. The compa...
- Eli Lilly's Once-Weekly Insulin Shows Non-Inferior Blood Sugar Reduction Vs Frequently Used Daily Insulins In Long Term Trials
- Eli Lilly's Once-Weekly Insulin Trials Show S...
Wednesday, September 04, 2024
- QIAGEN Enters Collaboration With Eli Lilly To...
- Eli Lilly is a Great Momentum Stock: Should You Buy?
- BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race
- MHRA Finds No Evidence Supporting Link Betwee...
- Trade Pulse Power Inflow Alert: Eli Lilly Stock Rises Over 7 Points
- Eli Lilly And EVA Pharma Entered Into An Agre...